4.8 Article

Potent Dual BET/HDAC Inhibitors for Efficient Treatment of Pancreatic Cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

T. Conroy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Chemistry, Medicinal

Drug Discovery Targeting Bromodomain-Containing Protein 4

Zhiqing Liu et al.

JOURNAL OF MEDICINAL CHEMISTRY (2017)

Review Biochemistry & Molecular Biology

Inhibitors of histone deacetylase as antitumor agents: A critical review

Mohammed Manal et al.

BIOORGANIC CHEMISTRY (2016)

Review Oncology

Targeting bet bromodomain proteins in solid tumors

Vaibhav Sahai et al.

ONCOTARGET (2016)

Article Medicine, General & Internal

Pancreatic cancer

Jorg Kleeff et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

Review Biotechnology & Applied Microbiology

Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders

Katrina J. Falkenberg et al.

NATURE REVIEWS DRUG DISCOVERY (2014)

Review Biotechnology & Applied Microbiology

Targeting bromodomains: epigenetic readers of lysine acetylation

Panagis Filippakopoulos et al.

NATURE REVIEWS DRUG DISCOVERY (2014)

Review Oncology

Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis

Angela L. McCleary-Wheeler et al.

CANCER LETTERS (2013)

Article Medicine, General & Internal

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Daniel D. Von Hoff et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Review Biotechnology & Applied Microbiology

Epigenetic protein families: a new frontier for drug discovery

Cheryl H. Arrowsmith et al.

NATURE REVIEWS DRUG DISCOVERY (2012)

Review Oncology

A decade of exploring the cancer epigenome - biological and translational implications

Stephen B. Baylin et al.

NATURE REVIEWS CANCER (2011)

Article Multidisciplinary Sciences

Selective inhibition of BET bromodomains

Panagis Filippakopoulos et al.

NATURE (2010)